Wednesday, August 21, 2013

Merck needs to cut costs, says analyst

Merck & Co needs to undertake a "major restructuring" in the wake of lacklustre sales and recent R&D setbacks, according to analysts at Leerink Swann.

Seamus Fernandez and Ario Arabi write in a research report that pressure is building on Merck's management to improve R&D productivity, maintain operating margins and return cash to investors, and signs of a shake-up of the business would be "well received".

No comments: